Cellectis SA (NAS:CLLS)
$ 1.56 0 (0%) Market Cap: 154.13 Mil Enterprise Value: -15.24 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 70/100

Q3 2020 Cellectis SA Earnings Call Transcript

Nov 06, 2020 / 01:00PM GMT
Release Date Price: $17.06 (-5.90%)
Operator

Greetings, and welcome to the Cellectis Q3 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Simon Harnest, Senior Vice President, Strategy and Finance.

Simon Harnest
Cellectis S.A. - SVP of Corporate Strategy & Finance

Thank you, and welcome, everyone, to Cellectis third quarter 2020 corporate update and financial results conference call. Joining me on the call today with prepared remarks are Dr. André Choulika, our Chief Executive Officer; Dr. Carrie Brownstein, our Chief Medical Officer; and Eric Dutang, our Chief Financial Officer.

Yesterday evening, Cellectis issued a press release reporting our financial results for the second (sic) [third] quarter ended September 30, 2020. The press release is available on our website at cellectis.com.

As a reminder, we will make forward-looking statements regarding financial outlook in addition to regulatory and product development plans. These statements are subject to risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot